Crossmark

Assessment of dopaminergic pathways in Huntington’s Disease: when, how, why? A (clinician-friendly) systematic review of the literature on PET and SPECT applications

Crossref DOI link: https://doi.org/10.1007/s40336-024-00651-2

Published Online: 2024-07-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Triumbari, Elizabeth Katherine Anna

Pizzuto, Daniele Antonio

Bentivoglio, Anna Rita

Piano, Carla

Annunziata, Salvatore

Meduri, Guido Maria

Di Giuda, Daniela
License Information

Text and Data Mining valid from 2024-07-19

Version of Record valid from 2024-07-19
More Information

Article History

Received: 2 April 2024

Accepted: 27 June 2024

First Online: 19 July 2024

Declarations

:

: The authors have no conflict of interest to disclose.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below